About this trial
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Self-identify as either Chinese or Korean
Speak either Korean, Mandarin, or English
Are 18 years of age or older
Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)
Disqualifiers
Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
Adults unable to consent.
Adults younger than 50 or older than 80 years
Individuals who are not yet adults (infants, children, teenagers)
Trial design
Parallel
Treatments tested in this trial
ACT Lung Health Intervention
BehavioralAn Asian culture-tailored lung health intervention, which includes individual counseling sessions, family coaching, provision of nicotine replacement therapy (NRT) in the form of patches, lozenges, or chewing gum, and educational materials about low-dose computed tomography (LDCT) for lung cancer screening. The eight weekly, counseling sessions with study staff will be conducted via phone call or the Zoom web-conferencing platform.
Treatment groups
Trial outcomes
Primary outcomes
Biochemically Verified 7-Day Point Prevalence Smoking Abstinence at 6 Months (Group A)
The proportion of participants who have not smoked cigarettes (not even a puff) in the past 7 days at the 6-month follow-up, verified biochemically using salivary cotinine testing. Participants reporting abstinence and not using nicotine replacement therapy (NRT) will perform a salivary cotinine test observed via video call. Cotinine levels ≤3 ng/mL will confirm abstinence.
Biochemically Verified 7-Day Point Prevalence Smoking Abstinence at 6 Months (Group B)
The proportion of participants who have not smoked cigarettes (not even a puff) in the past 7 days at the 6-month follow-up, verified biochemically using salivary cotinine testing. Participants reporting abstinence and not using nicotine replacement therapy (NRT) will perform a salivary cotinine test observed via video call. Cotinine levels ≤3 ng/mL will confirm abstinence.
Secondary outcomes
Change in Number of Cigarettes Smoked per Day from Baseline to 6 Months (Group A)
The mean change in the number of cigarettes smoked by participants per day from baseline to 6 months post-baseline.
Change in Number of Cigarettes Smoked per Day from Baseline to 6 Months (Group B)
The mean change in the number of cigarettes smoked by participants per day from baseline to 6 months post-baseline.
Self-Reported 7-Day Point Prevalence Smoking Abstinence at 3 Months (Group A)
The proportion of participants who self-report not smoking cigarettes (not even a puff) in the past 7 days at the 3-month follow-up.
Self-Reported 7-Day Point Prevalence Smoking Abstinence at 3 Months (Group B)
The proportion of participants who self-report not smoking cigarettes (not even a puff) in the past 7 days at the 3-month follow-up.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Dana-Farber Cancer Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator
University of Massachusetts, Boston
Collaborator